Latanoprost, identified by its CAS number 130209-82-4, is a compound of significant importance in the pharmaceutical industry, particularly within the realm of ophthalmology. As a prostaglandin analogue, it plays a critical role in the synthesis of medications designed to manage elevated intraocular pressure, a key factor in conditions such as open-angle glaucoma. Understanding Latanoprost as a pharmaceutical intermediate involves examining its chemical profile, therapeutic actions, and the importance of sourcing it from reliable manufacturers.

Chemically, Latanoprost is an ester prodrug that, upon absorption into the eye, is hydrolyzed into its active form, latanoprost acid. This active metabolite then works by increasing the outflow of aqueous humor through the uveoscleral pathway, thereby effectively lowering intraocular pressure. This specific mechanism of action is why it is so highly valued in the development of anti-glaucoma treatments. The purity and quality of the Latanoprost intermediate are therefore paramount to the efficacy of the final drug product.

For procurement managers and R&D scientists, the ability to buy Latanoprost API from a trusted manufacturer is crucial. We pride ourselves on being a premier supplier, offering Latanoprost with guaranteed high purity and consistent quality, backed by certifications such as GMP and ISO 9001. This ensures that our clients receive a product that adheres to the highest pharmaceutical standards, facilitating smooth integration into their manufacturing processes.

The market for Latanoprost is driven by the ongoing need for effective glaucoma treatments. As a key pharmaceutical intermediate, its availability and price point are significant considerations for companies looking to develop or produce ophthalmic medications. We provide transparent pricing and responsive customer service to support your purchasing decisions, whether for research quantities or large-scale production.

In essence, Latanoprost is more than just a chemical compound; it's a vital building block for advanced eye care. By understanding its role as a pharmaceutical intermediate and partnering with a dependable manufacturer, pharmaceutical companies can ensure the quality and accessibility of treatments that improve patients' vision and quality of life.